1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Glenmark Life Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
58.70% Gain from 52W Low
-12
TTM PE Ratio
Below industry Median
29.3
Price to Book Ratio
Above industry Median
5.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.8
Glenmark Life Sciences Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
1,020.80
10Day EMA
1,030.30
12Day EMA
1,033.80
20Day EMA
1,044.70
26Day EMA
1,050.80
50Day EMA
1,062.10
100Day EMA
1,041.20
200Day EMA
964.50
5Day SMA
1,020.40
10Day SMA
1,027.60
20Day SMA
1,053.40
30Day SMA
1,063.50
50Day SMA
1,072.90
100Day SMA
1,074.00
150Day SMA
1,000.30
200Day SMA
948.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 43176 Rs | 94531 Rs |
Week Rs | 36929 Rs | 76534 Rs |
Month Rs | 77411 Rs | 123095 Rs |
Resistance & Support
1,016.27
Pivot
Resistance
First Resistance
1,027.03
Second Resistance
1,040.77
Third Resistance
1,051.53
Support
First Support
1,002.53
Second support
991.77
Third Support
978.03
Relative Strength Index
40.88
Money Flow Index
56.64
MACD
-17.08
MACD Signal
-13.39
Average True Range
39.65
Average Directional Index
17.60
Rate of Change (21)
-6.18
Rate of Change (125)
22.12
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
14365.33 | 365.45 | 721 | ||
13816.96 | 130 | 358.7 | ||
Orchid Pharma Ltd. | - | - | - | |
14191.09 | 5892.8 | 10524.95 | ||
9787.79 | 324 | 603 | ||
11077.38 | 4211.55 | 5375 |
Glenmark Life Sciences Ltd Company background
Founded in: 2011
Managing director: Yasir Yusufali Rawjee
Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited, on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited dated 10 August 2018. A shareholders resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited. The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKlines (GSK) API manufacturing plant in Ankleshwar, Gujarat in 2003. It established manufacturing plant at Kurkumbh, Maharashtra in 2002. In 2004, it commenced manufacturing at Mohol, Maharashtra. In 2013, the Company commenced manufacturing at Dahej, Gujarat. The Company increased its API manufacturing capabilities by enhancing the existing production capacities at Ankleshwar Dahej facilities in FY 2023, by an aggregate annual total installed capacity of 640 KL.The Company expanded projects with additional 240 KL at Dahej in 2023. The brownfield expansion at Dahej for Oncology Plant was completed. Out of the 2 independent modules, one module commissioned 100%. 192 KL out of the 400 KL intermediate manufacturing block at Ankleshwar commissioned in 2023. The Company came up with an IPO of 21,022,222 Equity Shares comprising a Fresh Issue of 14,722,222 Equity Shares and Offer for Sale of 6,300,000 Equity Shares aggregating to Rs 1513.6 Crores in August, 2021.
Glenmark Life Sciences Ltd FAQs
What is the current share price of Glenmark Life Sciences Ltd today on both NSE and BSE?
Glenmark Life Sciences Ltd shares are currently priced at 1013.3 on NSE and 1012.55 on BSE as of 12/19/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.
How has Glenmark Life Sciences Ltd [GLS] shares performed in the past ?
The past 1-year return of Glenmark Life Sciences Ltd [GLS] share was 59.97. The Glenmark Life Sciences Ltd [GLS] share hit a 1-year low of Rs. 627.15 and a 1-year high of Rs. 1335.1.
What is the market cap of Glenmark Life Sciences Ltd [GLS] ?
The market cap of Glenmark Life Sciences Ltd is Rs. 12416.25 Cr. as of 12/19/2024 12:00:00 AM.
What is the current P/E ratio of Glenmark Life Sciences Ltd [GLS] share price ?
The PE ratios of Glenmark Life Sciences Ltd is 29.3 as of 12/19/2024 12:00:00 AM.
What is the current PB ratio of Glenmark Life Sciences Ltd [GLS] share price ?
The PB ratios of Glenmark Life Sciences Ltd is 4.88 as of 12/19/2024 12:00:00 AM
What is the Mutual Fund shareholding in Glenmark Life Sciences Ltd?
The Mutual Fund Shareholding was 2.82% at the end of 12/19/2024 12:00:00 AM.
How can I buy Glenmark Life Sciences Ltd shares?
You can easily buy Glenmark Life Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
